Analytica Limited Announcements http://www.AnalyticaMedical.com Australian Stock Exchange and Other Announcements by Analytica Limited. Saturday Sunday 1440 AutoStart Burette Recieves FDA 510(k) Clearance http://www.AnalyticaMedical.com/downloads/20100309-ASX-ALT-FDA510k.pdf Analytica Ltd is pleased to announce receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the AutoStart Burette in the United States. This is a significant milestone in the commercialisation of the AutoStart Burette, opening up one of the world's most significant medical device market. 9 Mar 2010 Appendix 3B http://www.AnalyticaMedical.com/downloads/20100302-ASX-ALT-Appendix3B.pdf New issue announcement, application for quotation of additional securities and agreement 2 Mar 2010 Form 603 http://www.AnalyticaMedical.com/downloads/20100302-ASX-ALT-Form603.pdf Notice of initial substantial holder 2 Mar 2010 Appendix 4D - Half Yearly Report http://www.AnalyticaMedical.com/downloads/20100226-ASX-ALT-Appendix4D.pdf For the 6 months ended December 2009 (current period) and the previous corresponding period 6 months ended 31 December 2008 26 Feb 2010 Market Update http://www.AnalyticaMedical.com/downloads/20100205-ASX-ALT-MarketUpdate.pdf Analytica Limited wishes to advise that its National Health and Medical Research Council (NHMRC) grant application has been unsuccessful. Analytica, in conjunction with Professor Paul Haber of the University of Sydney, applied for a NHMRC grant to partly fund the early stages of its Naltrexone implant program. Analytica is aiming to produce a TGA-approved Naltrexone implant for the treatment of drug and alcohol addiction. Currently, there is no generally available, TGA-approved implant to treat such addictions. 5 Feb 2010 Appendix 4C http://www.AnalyticaMedical.com/downloads/20100129-ASX-ALT-Appendix4C.pdf Analytica presents its Appendix 4C for the quarter ended 31 December 2009. 29 Jan 2010 Appendix 3B http://www.AnalyticaMedical.com/downloads/20100122-ASX-ALT-Appendix3B.pdf New issue announcement, application for quotation of additional securities and agreement. 22 Jan 2010 Market Update http://www.AnalyticaMedical.com/downloads/20091224-ASX-ALT-Update.pdf Further to the announcement to the market on 12 October 2009, Analytica Limited wishes to advise that its Pre-Market Notification (510(k)) application for the AutoStart® Burette is still under consideration by the FDA Office for Device Evaluation. Analytica understands that that the FDA workload is currently unusually high due to the agency's recent change in premises. Analytica is not aware of any impediment to the AutoStart® Burette receiving the required approvals from the FDA to be marketed in the United States and will advise the market of further developments as they occur. The Company also remains on target to complete a formal distribution and licensing agreement with Medical Australia Limited (MLA) in the New Year. The Agreement will provide MLA with an exclusive right for the distribution of the AutoStart® Burette in Australia, New Zealand and the UK, with a springboard into Asia, Europe and the middle east. 24 Dec 2009 Correction - Location of Share Register http://www.AnalyticaMedical.com/downloads/20091223-ASX-ALT-ShareRegisterCorx.pdf The announcement made by the Company on 21 December concerning the location of its share registry, Link Market Services, contained a typographical error. Link Market Services has relocated to Level 15, 324 Queen Street, Brisbane 4000. The previous announcement incorrectly stated Level 19. All telephone and fax numbers remain unchanged. 23 Dec 2009 Location of Share Register http://www.AnalyticaMedical.com/downloads/20091221-ASX-ALT-ShareRegister.pdf Analytica Limited (ASX: ALT) advises in accordance with Listing Rule 3.15.1, that the Company's share registry, Link Market Services, has relocated to Level 19, 324 Queen Street, Brisbane 4000. All telephone and fax numbers remain unchanged. 21 Dec 2009 Appendix 3B http://www.AnalyticaMedical.com/downloads/20091204-ASX-ALT-Appendix3B.pdf New issue announcement, application for quotation of additional securities and agreement. 4 Dec 2009 Appendix 3Y http://www.AnalyticaMedical.com/downloads/20091204-ASX-ALT-Appendix3Y.pdf Change of Director's Interest Notice. 4 Dec 2009 AGM 2009 - Results http://www.AnalyticaMedical.com/downloads/20091127-ASX-ALT-ResultsAGM2009.pdf 27 Nov 2009 AGM 2009 - Operations Report http://www.AnalyticaMedical.com/downloads/20091127-ASX-ALT-OperationsReport-AGM2009.pdf 27 Nov 2009 AGM 2009 - Chairman's Address http://www.AnalyticaMedical.com/downloads/20091127-ASX-ALT-ChairmansAddress-AGM2009.pdf 27 Nov 2009 Medical Australia and Analytica Sign Licensing and Distribution Heads of Agreement. http://www.AnalyticaMedical.com/downloads/20091126-ASX-ALT-MLA-HeadsOfAgreement.pdf

• Multifaceted agreement including the manufacture, regulatory sponsorship and marketing of the Analytica AutoStart® Burette device and AutoFlush feature.

• Exclusive distribution opportunity encompassing Australia, New Zealand and UK, with springboard into Asia, Middle East and EU.

• Long-term strategic alliance to form product development, commercialisation and distribution partnership.

 26 Nov 2009 Trading Halt http://www.AnalyticaMedical.com/downloads/20091125-ASX-ALT-TradingHalt.pdf ASX Market Release 25 Nov 2009 Trading Halt Request http://www.AnalyticaMedical.com/downloads/20091125-ASX-ALT-TradingHaltRequest.pdf Pursuant to listing Rule 17.1, Analytica Limited requests an immediate trading halt of the company's securities ("ASX: ALT") pending the release of a material announcement concerning the distribution of the company's AutoStart® Burette product. The company expects to make this announcement before the opening of trade on Friday morning (Nov 27). 25 Nov 2009 ASX Price Query Response http://www.AnalyticaMedical.com/downloads/20091105-ASX-ALT-ASXPriceQueryResponse.pdf Response to query by the ASX regarding recent price changes. 05 Nov 2009 First Commercial Sale of AutoStart® Burette http://www.AnalyticaMedical.com/downloads/20091030-ASX-ALT-1stASBSale.pdf Analytica is pleased to announce that it has received its first commercial order for the AutoStart® Burette following extensive trials with a State Government Hospital. This order marks a major milestone in the product lifecycle and moves Analytica's focus from development to production. 30 Oct 2009 Company Update - FDA 510(k) Application Acceptance http://www.AnalyticaMedical.com/downloads/20091012-ASX-ALT-FDA510kReceipt.pdf Analytica is pleased to announce that the US Food and Drug Administration has received and accepted a Premarket Notification (510(k)) application for the AutoStart® Burette. The 510(k) is a submission made to the FDA demonstrating that the AutoStart Burette is at least as safe and effective as existing legally marketed burette devices. Before supplying the AutoStart Burette to the US, Analytica must receive a letter from FDA which finds the device to be substantially equivalent and clears the device to be marketed. 510(k) clearances typically take several months. 12 Oct 2009 Appendix 4C - Quarterly Cash Flow http://www.AnalyticaMedical.com/downloads/20091001-ASX-ALT-Appendix4C.pdf Analytica presents its Appendix 4C for the quarter ended 30 September 2009. 01 Oct 2009 Notice of Annual General Meeting http://www.AnalyticaMedical.com/downloads/20090925-ASX-ALT-NoticeOfAnnualGeneralMeeting.pdf The Annual General Meeting of Analytica Ltd will be held at 10:00am (Brisbane time) Friday 27 November 2009 in the Heritage Function Room, The Glen Hotel, Corner Logan Road and Gaskell St, Eight Mile Plains. 25 Sep 2009 Annual Report for the year ended 30 June 2009 http://www.AnalyticaMedical.com/downloads/20090915-ASX-ALT-AnnualReport.pdf Annual Report. 15 Sep 2009 Appendix 4E http://www.AnalyticaMedical.com/downloads/20090827-ASX-ALT-Appendix4E.pdf Preliminary Final Report. 27 Aug 2009 Appendix 3Y http://www.AnalyticaMedical.com/downloads/20090827-ASX-ALT-Appendix3Y-MM.pdf Change of Director's Interest Notice (Dr M Monsour). 27 Aug 2009 Appendix 3Y http://www.AnalyticaMedical.com/downloads/20090827-ASX-ALT-Appendix3Y-DG.pdf Change of Director's Interest Notice (Mr D Gooch). 27 Aug 2009 Completion of Share Purchase Plan http://www.AnalyticaMedical.com/downloads/20090825-ASX-ALT-SPPCompletion.pdf Analytica Limited is pleased to announce that is has raised $879,245 from subscriptions under its recent Share Purchase Plan (SPP). All eligible applicants will receive their full entitlement. Allotment of SPP shares will take place effective 25 August 2009 with the dispatch of Allotment Notices expected to occur by 28 August. The funds raised under the SPP have exceeded the Boards expectations and will be used in bringing the AutoStart® Burette to market as well as meeting the Company's working capital requirements over the coming months. An Appendix 3B will follow this announcement. 25 Aug 2009 Appendix 3B http://www.AnalyticaMedical.com/downloads/20090825-ASX-ALT-Appendix3B.pdf New issue announcement, application for quotation of additional securities and agreement. 25 Aug 2009 Location of Share Register http://www.AnalyticaMedical.com/downloads/20090824-ASX-ALT-ShareRegisterLocation.pdf Analytica Limited advises in accordance with Listing Rule 3.15.1, that from Monday 24 August 2009, the Company's share registry, Link Market Services, will be located in the ANZ Building, Level 19, 324 Queen Street, Brisbane 4000. All telephone and fax numbers remain unchanged. 24 Aug 2009 AutoStart Burette Update http://www.AnalyticaMedical.com/downloads/20090813-ASX-ALT-ASBUpdate.pdf Analytica is pleased to announce its AutoStart® Burette has now formally completed its first in-hospital trial. This trial, conducted in a Queensland hospital, successfully demonstrated the effectiveness and usability of the AutoStart® Burette in a clinical environment. 13 Aug 2009 Appendix 4C - Quarterly Cash Flow and Unaudited Full-year Result http://www.AnalyticaMedical.com/downloads/20090731-ASX-ALT-Appendix4C.pdf Analytica Ltd presents its Appendix 4C for the quarter ended 30 June 2009. 31 Jul 2009 Passing of Mr Jim Heckathorn and Appendix 3Z http://www.AnalyticaMedical.com/downloads/20090722-ASX-ALT-JH-Appendix3Z.pdf It is with much sadness that the Board of Analytica Limited announces the passing of Director Mr. Jim Heckathorn. Mr. Heckathorn passed away overnight after a brief illness. An Appendix 3Z is attached to this announcement. 22 Jul 2009 Share Purchase Plan http://www.AnalyticaMedical.com/downloads/20090720-ASX-ALT-SPP-IneligibleShareholders.pdf Share Purchase Plan Letter to Ineligible Shareholders. 20 Jul 2009 Share Purchase Plan http://www.AnalyticaMedical.com/downloads/20090720-ASX-ALT-SPP-OptionHolder.pdf Share Purchase Plan Letter to Option Holders. 20 Jul 2009 Share Purchase Plan http://www.AnalyticaMedical.com/downloads/20090720-ASX-ALT-SPP-Shareholder.pdf Share Purchase Plan Letter to Eligible Shareholders. 20 Jul 2009 Share Purchase Plan http://www.AnalyticaMedical.com/downloads/20090720-ASX-ALT-SPP-Offer.pdf Share Purchase Plan Offer Document. 20 Jul 2009 Share Purchase Plan http://www.AnalyticaMedical.com/downloads/20090720-ASX-ALT-SPP-DisclosureNotice.pdf Share Purchase Plan Disclosure Notice. 20 Jul 2009 Share Purchase Plan http://www.AnalyticaMedical.com/downloads/20090720-ASX-ALT-SPP-Announce.pdf Analytica Limited is pleased to announce a Share Purchase Plan (SPP) to address its future funding needs. Under the SPP, we would like to invite eligible shareholders to participate by purchasing up to $15,000 of ALT ordinary shares without incurring brokerage or transaction costs. 20 Jul 2009 Company Update http://www.AnalyticaMedical.com/downloads/20090713-ASX-ALT-CompanyUpdate.pdf Analytica Limited is pleased to provide the attached update to the market on the Company's activities. 13 Jul 2009